Contract manufacturing for pharma APIs, injectables, and advanced therapeutics
Piramal Pharma Solutions operates a multi-continent CDMO network serving innovator and generic pharma companies across the full drug lifecycle. The tech stack—SAP, Salesforce, LIMS, analytical instrumentation (HPLC, UPLC, ICP-MS), and BI tools—reflects a manufacturing-operations-first org. Hiring is accelerating in manufacturing and ops roles, while projects center on scaling lab production, HPAPI/ADC manufacturing for clinical trials, and operational compliance systems, indicating capacity expansion and process maturation as core priorities.
Notable leadership hires: Quality Director
Piramal Pharma Solutions is a CDMO with facilities across North America, Europe, and Asia, providing drug discovery support, process development, clinical and commercial manufacturing, and specialized services including high-potency APIs, antibody-drug conjugates, sterile fill/finish, peptides, and oral solids. The organization serves both branded and off-patent segments. Current work spans manufacturing scale-up, continuous improvement programs (daily management, EHS systems, CAPA implementation), and operational discipline initiatives—including audit readiness and SOP development—signaling focus on GMP compliance and operational reliability.
SAP for ERP, Salesforce for CRM, LIMS for lab data, Power BI and Tableau for reporting, plus analytical instruments: HPLC, UPLC, and ICP-MS for characterization and quality control.
Lexington, Kentucky. The company operates a globally integrated network of manufacturing facilities across North America, Europe, and Asia.
Piramal Pharma Solutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.